SINOMAB BIO-B: Notification Letter to Non-registered Shareholders and Reply Form
SINOMAB BIO-B: Notification Letter to Registered Shareholders and Reply Form
SINOMAB BIO-B: NOTICE OF 2024 ANNUAL GENERAL MEETING
SINOMAB BIO-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 6, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ON FRIDAY, 14 JUNE 2024 AT 10:00 A.M.
SINOMAB BIO-B: PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND PROPOSED AMENDMENTS TO THE 2022 SHARE OPTION SCHEME AND PROPOSED REFRESHMENT OF SCHEME MANDATE LIMIT AND SERVICE PROVIDER SUBLIM
SINOMAB BIO-B: Annual Report 2023
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023; CHANGE IN USE OF PROCEEDS; PROPOSED AMENDMENT TO THE 2022 SHARE OPTION SCHEME; AND PROPOSED REFRESHMENT OF SCHEME MANDATE LIMIT AND SERVICE PROVIDER SUBLIMIT
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
SINOMAB BIO-B: Letter to Non-Registered Shareholders - Arrangements of Electronic Dissemination of Corporate Communications
SINOMAB BIO-B: Letter to Registered Shareholders - Arrangements of Electronic Dissemination of Corporate Communications
SINOMAB BIO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
SINOMAB BIO-B: APPOINTMENT OF EXECUTIVE DIRECTOR
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
SINOMAB BIO-B: Next Day Disclosure Return
SINOMAB BIO-B: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: Next Day Disclosure Return
SINOMAB BIO-B: COMPLETION OF CERTAIN SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
No Data